Your browser doesn't support javascript.
Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19.
Jaywant, Abhishek; Vanderlind, W Michael; Alexopoulos, George S; Fridman, Chaya B; Perlis, Roy H; Gunning, Faith M.
  • Jaywant A; Department of Psychiatry, Weill Cornell Medicine, New York, NY, US.
  • Vanderlind WM; Department of Rehabilitation Medicine, Weill Cornell Medicine, New York, NY, US.
  • Alexopoulos GS; NewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY, US.
  • Fridman CB; Department of Psychiatry, Weill Cornell Medicine, New York, NY, US.
  • Perlis RH; NewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY, US.
  • Gunning FM; Department of Psychiatry, Weill Cornell Medicine, New York, NY, US.
Neuropsychopharmacology ; 46(13): 2235-2240, 2021 12.
Article in English | MEDLINE | ID: covidwho-1085430
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
Early reports and case series suggest cognitive deficits occurs in some patients with COVID-19. We evaluated the frequency, severity, and profile of cognitive dysfunction in patients recovering from prolonged COVID-19 hospitalization who required acute inpatient rehabilitation prior to discharge. We analyzed cross-sectional scores from the Brief Memory and Executive Test (BMET) in a cohort of N = 57 COVID-19 patients undergoing inpatient rehabilitation, calculating the frequency of impairment based on neuropsychologist diagnosis and by age-normed BMET subtests. In total, 43 patients (75%) were male, 35 (61%) were non-white, and mean age was 64.5 (SD = 13.9) years. In total, 48 (84%) were previously living at home independently. Two patients had documented preexisting cognitive dysfunction; none had known dementia. Patients were evaluated at a mean of 43.2 (SD = 19.2) days after initial admission. In total, 50 patients (88%) had documented hypoxemic respiratory failure and 44 (77%) required intubation.  Forty-six patients (81%) had cognitive impairment, ranging from mild to severe. Deficits were common in working memory (26/47 [55%] of patients), set-shifting (21/44 [47%]), divided attention (18/39 [46%]), and processing speed (14/35 [40%]). Executive dysfunction was not significantly associated with intubation length or the time from extubation to assessment, psychiatric diagnosis, or preexisting cardiovascular/metabolic disease. Attention and executive functions are frequently impaired in COVID-19 patients who require acute rehabilitation prior to discharge. Though interpretation is limited by lack of a comparator group, these results provide an early benchmark for identifying and characterizing cognitive difficulties after COVID-19. Given the frequency and pattern of impairment, easy-to-disseminate interventions that target attention and executive dysfunctions may be beneficial to this population.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cognitive Dysfunction / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans / Male / Middle aged Language: English Journal: Neuropsychopharmacology Journal subject: Neurology / Psychopharmacology Year: 2021 Document Type: Article Affiliation country: S41386-021-00978-8

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Cognitive Dysfunction / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans / Male / Middle aged Language: English Journal: Neuropsychopharmacology Journal subject: Neurology / Psychopharmacology Year: 2021 Document Type: Article Affiliation country: S41386-021-00978-8